Cargando…
Cancer 3D Models for Metallodrug Preclinical Testing
Despite being standard tools in research, the application of cellular and animal models in drug development is hindered by several limitations, such as limited translational significance, animal ethics, and inter-species physiological differences. In this regard, 3D cellular models can be presented...
Autores principales: | Engrácia, Diogo M., Pinto, Catarina I. G., Mendes, Filipa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418685/ https://www.ncbi.nlm.nih.gov/pubmed/37569291 http://dx.doi.org/10.3390/ijms241511915 |
Ejemplares similares
-
Target-directed catalytic metallodrugs
por: Joyner, J.C., et al.
Publicado: (2013) -
Metallodrugs: an approach against invasion and metastasis in cancer treatment
por: González‐Ballesteros, Mauricio M., et al.
Publicado: (2022) -
Polyoxometalates as Potential Next‐Generation Metallodrugs in the Combat Against Cancer
por: Bijelic, Aleksandar, et al.
Publicado: (2018) -
Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment
por: Páez-Franco, José C., et al.
Publicado: (2022) -
DNA-Metallodrugs Interactions Signaled by Electrochemical Biosensors: An Overview
por: Ravera, Mauro, et al.
Publicado: (2007)